37 CFR 1.98 — Content of information disclosure statement
Ninth Edition, Revision 01.2024
- (a) Any information disclosure statement filed under §
1.97
shall
include the items listed in paragraphs (a)(1), (a)(2) and (a)(3) of
this section.
- (1) A list of all patents, publications,
applications, or other information submitted for
consideration by the Office. U.S. patents and U.S. patent
application publications must be listed in a section
separately from citations of other documents. Each page of
the list must include:
- (i) The application number of the application in which the information disclosure statement is being submitted;
- (ii) A column that provides a space, next to each document to be considered, for the examiner’s initials; and
- (iii) A heading that clearly indicates that the list is an information disclosure statement.
- (2) A legible copy of:
- (i) Each foreign patent;
- (ii) Each publication or that portion which caused it to be listed, other than U.S. patents and U.S. patent application publications unless required by the Office;
- (iii) For each cited pending unpublished U.S. application, the application specification including the claims, and any drawing of the application, or that portion of the application which caused it to be listed including any claims directed to that portion [but see 1287 OG 163 (October 19, 2004) discussed in MPEP § 609.04(a), subsection II]; and
- (iv) All other information or that portion which caused it to be listed.
- (3)
- (i) A concise explanation of the relevance, as it is presently understood by the individual designated in § 1.56(c) most knowledgeable about the content of the information, of each patent, publication, or other information listed that is not in the English language. The concise explanation may be either separate from applicant’s specification or incorporated therein.
- (ii) A copy of the translation if a written English-language translation of a non-English-language document, or portion thereof, is within the possession, custody, or control of, or is readily available to any individual designated in § 1.56(c) .
- (1) A list of all patents, publications,
applications, or other information submitted for
consideration by the Office. U.S. patents and U.S. patent
application publications must be listed in a section
separately from citations of other documents. Each page of
the list must include:
- (b)
- (1) Each U.S. patent listed in an information disclosure statement must be identified by inventor, patent number, and issue date.
- (2) Each U.S. patent application publication listed in an information disclosure statement shall be identified by applicant, patent application publication number, and publication date.
- (3) Each U.S. application listed in an information disclosure statement must be identified by the inventor, application number, and filing date.
- (4) Each foreign patent or published foreign patent application listed in an information disclosure statement must be identified by the country or patent office which issued the patent or published the application, an appropriate document number, and the publication date indicated on the patent or published application.
- (5) Each publication listed in an information disclosure statement must be identified by publisher, author (if any), title, relevant pages of the publication, date, and place of publication.
- (c) When the disclosures of two or more patents or publications listed in an information disclosure statement are substantively cumulative, a copy of one of the patents or publications as specified in paragraph (a) of this section may be submitted without copies of the other patents or publications, provided that it is stated that these other patents or publications are cumulative.
- (d) A copy of any patent, publication, pending U.S.
application or other information, as specified in paragraph (a) of
this section, listed in an information disclosure statement is
required to be provided, even if the patent, publication, pending
U.S. application or other information was previously submitted to,
or cited by, the Office in an earlier application, unless:
- (1) The earlier application is properly identified in the information disclosure statement and is relied on for an earlier effective filing date under 35 U.S.C. 120 ; and
- (2) The information disclosure statement submitted in the earlier application complies with paragraphs (a) through (c) of this section.
[42 FR 5594, Jan. 28, 1977; para. (a) 48 FR 2696, Jan. 20, 1983, effective date Feb. 27, 1983; 57 FR 2021, Jan. 17, 1992, effective Mar. 16, 1992; revised, 65 FR 54604, Sept. 8, 2000, effective Nov. 7, 2000; paras. (a)(2) and (b) revised, 65 FR 57024, Sept. 20, 2000, effective Nov. 29, 2000; para. (e) added, 68 FR 38611, June 30, 2003, effective July 30, 2003; paras. (a) and (c) revised and para. (e) removed, 69 FR 56481, Sept. 21, 2004, effective Oct. 21, 2004]
Cited authority
Cited by
- 1134.01 Third Party Submissions Under 37 CFR 1.290
- 1206 Amendments and Affidavits or Other Evidence Filed With or After Appeal
- 1308 Withdrawal From Issue
- 1406 Citation and Consideration of References Cited in Original Patent
- 1418 Notification of Prior/Concurrent Proceedings and Decisions Thereon, and of Information Known To Be Material to Patentability
- 1455 Allowance and Issue
- 1504.04 Considerations Under 35 U.S.C. 112
- 1504.30 Expedited Examination
- 1893.03(g) Information Disclosure Statement in a National Stage Application
- 2001 Duty of Disclosure, Candor, and Good Faith
- 2001.04 Information Under 37 CFR 1.56(a)
- 201.06(d) 37 CFR 1.53(d) Continued Prosecution Application (CPA) Practice
- 2214 Content of Request for Ex Parte Reexamination Filed under 35 U.S.C. 302
- 2218 Copies of Prior Art
- 2244 Prior Art on Which the Determination Is Based in Requests Filed under 35 U.S.C. 302
- 2256 Prior Art Patents and Printed Publications Reviewed by Examiner in Reexamination
- 2257 Listing of Prior Art
- 2258.01 Use of Previously Cited/Considered Art in Rejections
- 2280 Information Material to Patentability in Reexamination Proceeding Filed under 35 U.S.C. 302
- 2730 Applications Filed on or After May 29, 2000; Grounds for Adjustment
- 2732 Reduction of Period of Adjustment of Patent Term
- 2811 Content of Request for Supplemental Examination
- 2920.05(f) Information Disclosure Statement in an International Design Application Designating the United States
- 601 Content of Provisional and Nonprovisional Applications
- 608.01(a) Arrangement of Application
- 608.01(c) Background of the Invention
- 609 Information Disclosure Statement
- 609.01 Examiner Checklist for Information Disclosure Statements
- 609.02 Information Disclosure Statements in Continued Examinations or Continuing Applications
- 609.03 Information Disclosure Statements in National Stage Applications
- 609.04(a) Content Requirements for an Information Disclosure Statement
- 609.04(b) Timing Requirements for an Information Disclosure Statement
- 609.05 Examiner Handling of Information Disclosure Statements
- 609.05(a) Noncomplying Information Disclosure Statements
- 609.05(b) Complying Information Disclosure Statements
- 609.05(c) Documents Submitted as Part of Applicant’s Reply to Office Action
- 609.07 IDSs Electronically Submitted (eIDS) Using Patent Center
- 704.14(b) Examiner’s Obligation Following Applicant’s Reply
- 704.14(d) Relationship to Information Disclosure Statements
- 706.07(g) Transitional After-Final Practice
- 706.07(h) Request for Continued Examination (RCE) Practice
- 707.05 Citation of References
- 708.02(a) Accelerated Examination
- 710.02(c) Specified Time Limits: Situations in Which Used
- 714.16 Amendment After Notice of Allowance, 37 CFR 1.312
- 719.05 Field of Search
- 37 CFR 1.51 General requisites of an application
- 37 CFR 1.56 Duty to disclose information material to patentability
- 37 CFR 1.97 Filing of information disclosure statement
- 37 CFR 1.155 Expedited examination of design applications
- 37 CFR 1.555 Information material to patentability in ex parte reexamination and inter partes reexamination proceedings
- 37 CFR 1.610 Content of request for supplemental examination
- 37 CFR 1.704 Reduction of period of adjustment of patent term